Update 2008, Q3 Live!

₄Alexis Elbaz

Summary for 2003 [at-glance overview of Alexis Elbaz work for the selected year as suggested by data mining algorithms]

This is an Authoratory overview of author Alexis Elbaz. According to available data, in 2003 Alexis Elbaz published at least 4 articles. This work was completed in collaboration with several authors including Amouyel, Philippe and Tzourio, Christophe. Many other authors have collaborated with Alexis Elbaz as well. There is no information about the funding or the grants awarded to support this work.

Alexis Elbaz has rank 273 when compared to all other authors using the keyword Parkinson Disease. Analysis of the article abstracts and the titles suggests that Alexis Elbaz professional interests are focused around "community-based case-control study", "polymorphism confidence interval" and "polymorphisms brain infarction". These might also be referred to as "parkinson disease", "carriers allele" or "mpo polymorphisms". Statistical analysis shows that Alexis Elbaz's writing is likely to contains terms "polymorphisms", "study", "ci", "allele", "polymorphism" and "association".

Unfortunately, there is not enough information to establish Alexis Elbaz affiliation. Luckily, one email address is on file.

EN FR ES RU

leave comment ask question

Other [context-specific ads]

Alternative names (1) [other authors with names similar to Alexis Elbaz]

₁₇Elbaz, A

Year 2003 Charts [Alexis Elbaz frequent coauthors and the most common unique vocabulary terms for the selected year]

Historical Performance Charts [graphical overview of Alexis Elbaz publication and funding history for the range of years]

Emails (1) [email addresses extracted from Alexis Elbaz affiliations]

hidden to prevent spam, click here to reveal

Alexis Elbaz Coauthors (19) [all coauthors with the number of joint publications]

2

2

2

2

2

2

₂Chartier-Harlin, Marie-Christine

2

₂Vidal, Jean-Sébastien

1

₁₆Visvikis, Sophie

1

₁₃Siest, Gérard

1

₁₁Schaid, Daniel J

1

₇McDonnell, Shannon K

1

₇Poirier, Odette

1

₆Ahlskog, J Eric

1

₅Amarenco, Pierre

1

₅Maraganore, Demetrius M

1

₅Rocca, Walter A

1

₄Bower, James H

1

₃Peterson, Brett J

1

₂Leininger-Muller, Brigitte

Affiliations (4) [condensed summary of the Alexis Elbaz affiliations, the leading number and the color conveys importance]

₁Inserm Unité 525 équipe 4, Centre de Médecine Préventive, 2 avenue du Doyen Jacques Parisot, 54501 Vandoeuvre-Les-Nancy, Nancy, France.
₁Institut National de la Santé et de la Recherche Médicale, Unit 360, Hôpital de la Salpêtrière, Paris, France.
₁Department of Health Sciences Research, Mayo Clinic and Mayo Foundation, Rochester, MN 55905, USA.
₁INSERM Unit 508 Institut Pasteur de Lille, 59019 Lille, France.

Key Opinion Leader In [Alexis Elbaz is considered a key opinion leader in any keyword where the rank of 5 is achieved, the leading number before the keyword shows the author's rank as compared to all other authors]

₂₇₃Parkinson Disease | ₇₆₈Case-Control Studies

Keywords (32) [keywords assigned to Alexis Elbaz articles by PubMed, the leading number and the color conveys importance]

₄Humans | ₃Male | ₃Female | ₃Middle Aged | ₃Aged | ₃Parkinson Disease | ₃Adult | ₃Case-Control Studies | ₂Adolescent | ₂Genotype | ₂Polymorphism, Genetic | ₂Genetic Predisposition to Disease | ₂Aged, 80 and over | ₂Smoking | ₁Environmental Exposure | ₁Nitric Oxide Synthase Type II | ₁Stroke | ₁Neutrophils | ₁Brain Infarction | ₁Nitrates | ₁Peroxidase | ₁Base Sequence | ₁Survival Analysis | ₁Nitric Oxide Synthase | ₁Age of Onset | ₁Odds Ratio | ₁Alleles | ₁Insurance, Health | ₁Nitric Oxide Synthase Type I | ₁Cohort Studies | ₁Minnesota | ₁Age Factors

Alexis Elbaz Unique Vocabulary (96) [single words, word pairs and phrases obtained by analysis of abstracts and titles, the leading number and the color conveys importance; Alexis Elbaz might be a good expert witness on these terms]

₁₁polymorphisms | ₉study | ₉ci | ₉allele | ₉polymorphism | ₈association | ₈mpo | ₈pd | ₇nnos | ₇carriers | ₇patients | ₆parkinson | ₆bi | ₆disease | ₅brain | ₄functional | ₄g-129a | ₄risk | ₄outcome | ₄case-control | ₄genes | ₄smoking | ₄g-463a | ₄community-based | ₃myeloperoxidase | ₃infarct | ₃infarction | ₃inos | ₃controls | ₃size | ₃age | ₂subjects
₆parkinson disease | ₅carriers allele | ₄mpo polymorphisms | ₄community-based case-control | ₄case-control study | ₄confidence interval | ₄polymorphism confidence | ₃functional outcome | ₃brain infarction | ₃g-129a polymorphism | ₃polymorphisms brain | ₃allele g-129a | ₃years rr | ₃patients pd | ₃allele g-463a | ₃rr ci | ₃g-463a polymorphism | ₂genes community-based | ₂polymorphisms nnos | ₂association infarct | ₂inos genes | ₂infarct size | ₂disease polymorphisms | ₂size functional | ₂association parkinson | ₂myeloperoxidase polymorphisms | ₂nnos inos | ₂age-dependent relationship | ₂ci 08-2 | ₂study parkinson | ₂olmsted county | ₂risk developing
₄community-based case-control study | ₄polymorphism confidence interval | ₃polymorphisms brain infarction | ₃allele g-129a polymorphism | ₃allele g-463a polymorphism | ₃years rr ci | ₂myeloperoxidase polymorphisms brain | ₂inos genes community-based | ₂size functional outcome | ₂nnos inos genes | ₂association parkinson disease | ₂polymorphisms nnos inos | ₂association infarct size | ₂genes community-based case-control | ₂disease polymorphisms nnos | ₂infarct size functional | ₂parkinson disease polymorphisms | ₂g-129a polymorphism confidence | ₂g-463a polymorphism confidence | ₂parkinson disease olmsted | ₂evidence age-dependent relationship | ₂olmsted county minnesota | ₂disease olmsted county | ₂gene parkinson disease | ₂exon nnos carriers | ₂bi carriers allele | ₂survival study parkinson | ₂uch-l1 gene parkinson | ₂study parkinson disease | ₂carriers allele ci | ₂polymorphism uch-l1 gene | ₂nnos carriers allele

Reader's Comments (0) [comments posted by readers of Alexis Elbaz profile]